Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy

Oncogene

Volumn 30, Issue 6, 2011, Pages 690-700

  Tommasi, S ^a   Besaratinia, A ^a   Wilczynski, S P ^a   Pfeifer, G P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

aneuploidy; chromosomal abnormalities; cytokinesis; tetraploidy; tumor suppressor gene

Indexed keywords

PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ANEUPLOIDY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE REGULATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FERTILE PERIOD; FLUORESCENCE ACTIVATED CELL SORTING; GENE LOSS; GENOMIC INSTABILITY; KNOCKOUT MOUSE; LYMPHOMA; MALE; MITOSIS; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SARCOMA; SURVIVAL TIME; TETRAPLOIDY; TUMOR GROWTH; TUMOR VOLUME;

ANEUPLOIDY; ANIMALS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; LYMPHOMA; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS; SARCOMA; TETRAPLOIDY; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MUS; PYRONIA TITHONUS;

EID: 79951515601     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.440     Document Type: Article

References (50)

1. Agathanggelou A, Cooper WN, Latif F. (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497-3508. (Pubitemid 40616319)
2. Attardi LD, de Vries A, Jacks T. (2004). Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 23: 973-980. (Pubitemid 38250943)
3. Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP et al. (2005). The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell 18: 637-650. (Pubitemid 40804800)
4. Burds AA, Lutum AS, Sorger PK. (2005). Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proc Natl Acad Sci USA 102: 11296-11301. (Pubitemid 41153814)
5. Caldwell CM, Green RA, Kaplan KB. (2007). APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 178: 1109-1120. (Pubitemid 47480220)
6. Chi YH, Ward JM, Cheng LI, Yasunaga J, Jeang KT. (2008). Spindle assembly checkpoint and p53 deficiencies cooperate for tumori-genesis in mice. Int J Cancer 124: 1483-1489.
7. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL et al. (1995). A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356.
8. Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD et al. (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64: 4112-4116. (Pubitemid 38802412)
9. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319. (Pubitemid 30437320)
10. Dammann R, Schagdarsurengin U, Strunnikova M, Rastetter M, Seidel C, Liu L et al. (2003). Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol 18: 665-67.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Mice deficient for p53 are developmen-tally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
12. Donninger H, Vos MD, Clark GJ. (2007). The RASSF1A tumor suppressor. J Cell Sci 120: 3163-3172. (Pubitemid 350018407)
13. Duensing A, Duensing S. (2005). Guilt by association p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 331: 694-700. (Pubitemid 40615499)
14. Foley CJ, Freedman H, Choo SL, Onyskiw C, Fu NY, Yu VC et al. (2008). Dynamics of RASSF1A/MOAP-1 association with death receptors. Mol Cell Biol 28: 4520-4535. (Pubitemid 351977751)
15. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. (2005). Cytokinesis failure generating tetraploids promotes tumor-igenesis in p53-null cells. Nature 437: 1043-1047. (Pubitemid 41486987)
16. Fukasawa K, Wiener F, Vande Woude GF, Mai S. (1997). Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 15: 1295-1302. (Pubitemid 27429745)
17. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS et al. (1996). 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 93: 7081-7084. (Pubitemid 26243505)
18. Ganem NJ, Storchova Z, Pellman D. (2007). Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162. (Pubitemid 46551722)
19. Giaretti W. (1994). A model of DNA aneuploidization and evolution in colorectal cancer. Lab Invest 71: 904-910.
20. Giono LE, Manfredi JJ. (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209: 13-20. (Pubitemid 44318664)
21. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. (2007). RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol 17:700-705. (Pubitemid 46552245)
22. Holland AJ, Cleveland DW. (2009). Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10: 478-487.
23. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. (1994). Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7.
24. Lanni JS, Jacks T. (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18: 1055-1064. (Pubitemid 28063440)
25. Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP. (2003). Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22: 8125-8136. (Pubitemid 37487303)
26. Liu L, Vo A, McKeehan WL. (2005). Specificity of the methylation- suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5. Cancer Res 65: 1830-1838. (Pubitemid 40478611)
27. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
28. Lobrich M, Jeggo PA. (2007). The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7: 861-869. (Pubitemid 350006255)
29. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D et al. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962-975. (Pubitemid 47495894)
30. Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. (2004). Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381: 453-462. (Pubitemid 38969690)
31. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE et al. (1994). Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9: 603-609.
32. Rabizadeh S, Xavier RJ, Ishiguro K, Bernabeortiz J, Lopez-Ilasaca M, Khokhlatchev A et al. (2004). The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem 279: 29247-29254. (Pubitemid 38915800)
33. Richter AM, Pfeifer GP, Dammann RH. (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 1796: 114-128.
34. Segers P, Haesen S, Amy JJ, De Sutter P, Van Dam P, Kirsch-Volders M. (1994). Detection of premalignant stages in cervical smears with a biotinylated probe for chromosome 1. Cancer Genet Cytogenet 75: 120-129. (Pubitemid 24269989)
35. Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB et al. (2009). p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle 8: 1380-1385.
36. Shi Q, King RW. (2005). Chromosome nondisjunction yields tetra-ploid rather than aneuploid cells in human cell lines. Nature 437: 1038-1042. (Pubitemid 41486986)
37. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318. (Pubitemid 34556598)
38. Song MS, Chang JS, Song SJ, Yang TH, Lee H, Lim DS. (2005). The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles. J Biol Chem 280: 3920-3927. (Pubitemid 40223861)
39. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK et al. (2004). The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129-137. (Pubitemid 38425712)
40. Storchova Z, Kuffer C. (2008). The consequences of tetraploidy and aneuploidy. J Cell Sci 121: 3859-3866.
41. Storchova Z, Pellman D. (2004). From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45-54. (Pubitemid 38089840)
42. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM et al. (2005). Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92-98. (Pubitemid 40070799)
43. van der Weyden L, Adams DJ. (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776: 58-85. (Pubitemid 47332074)
44. van der Weyden L, Tachibana KK, Gonzalez MA, Adams DJ, Ng BL, Petty R et al. (2005). The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol 25: 8356-8367. (Pubitemid 41263023)
45. Verdoodt B, Castelain P, Bourgain C, Kirsch-Volders M. (1994). Aneuploidy for chromosome 1 and overall DNA content in benign and malignant breast disease. Cancer Genet Cytogenet 78: 53-63. (Pubitemid 24378606)
46. Vogel C, Kienitz A, Hofmann I, Muller R, Bastians H. (2004). Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy. Oncogene 23: 6845-6853. (Pubitemid 39279985)
47. Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F et al. (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64: 4244-4250. (Pubitemid 38802429)
48. Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ. (2003). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. J Biol Chem 278: 21938-21943.
49. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J et al. (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267. (Pubitemid 43929093)
50. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. (2009). Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocel-lular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425-438.